The Lead Episode 71: A Discussion of Fascicular Substrate Modification to Treat Human Ventricular Fibrillation-The Lead Episode 71 Speaker Information

The Lead Episode 71 Speaker Information

Pdf Summary

The discussion centered around the topic of fascicular substrate modification as a treatment for human ventricular fibrillation. The host, William H. Sauer, MD, led the conversation with contributors including Babak Nazer, MD, and Andrés Felipe Miranda-Arboleda, MD. The authors of the article discussed were Weeranun D. Bode, MD, Sanghamitra Mohanty, MD, John D. Burkhardt, MD, and others. The publication where the article appeared was the Journal of the American College of Cardiology: Clinical Electrophysiology. <br /><br />The contributors disclosed their affiliations with various companies such as Biotronik, Biosense Webster, Inc., and Medtronic. They also mentioned their involvement in research projects with companies like Abbott, Boston Scientific, and Edwards Lifesciences. The discussion shed light on the importance of fascicular substrate modification in managing ventricular fibrillation. The meeting was held at Brigham and Women's Hospital, where Dr. Sauer is associated. Dr. Nazer is from the University of Washington, while Dr. Miranda-Arboleda is also from Brigham and Women's Hospital. The event provided insights into the ongoing research and advancements in treating ventricular fibrillation, an important aspect of cardiac care.

Keywords

fascicular substrate modification

ventricular fibrillation

William H. Sauer

Babak Nazer

Andrés Felipe Miranda-Arboleda

Journal of the American College of Cardiology: Clinical Electrophysiology

Biotronik

Brigham and Women's Hospital

cardiac care

research projects